NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter
Press Release
Read More
Quantitative single cell analysis of cell population dynamics during submandibular salivary gland development and differentiation
Literature
Read More
NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012
Press Release
Read More
NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013
Press Release
Read More
NeoGenomics Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer
Press Release
Read More
Feasibility of Peripheral Blood Sampling and Correlation Between Early and Late Responses in Patients With Ph+ CML in Chronic Phase: Post-Hoc Analyses of Molecular Monitoring of Imatinib Response in the RIGHT Study
Literature
Read More